Olivier Rixe is a Clinical & Scientific Advisor at Bexion Pharmaceuticals. Olivier has also served as VP-Early Clinical Development at Daiichi Sankyo, Inc., Founder, Director and Principal Investigator at Quantum Santa Fe, Cancer Center Associate Director, Clinical Research/Professor of Medicine at University of New Mexico Comprehensive Cancer Center, and Director, Experimental Therapeutics Program/Professor of Medicine at Medical College of Georgia at Georgia Regents University. Olivier Rixe has also been a Staff Clinician at National Cancer Institute and Professor of Medicine/Medical Oncology at Pierre and Marie Curie University.
Olivier Rixe holds a PhD in Molecular Biology from Université de Paris, as well as a Doctor of Medicine from Pierre and Marie Curie University.